TÜRKEŞ, C. Et Al. 2015. Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , vol.30, no.4 , 622-628.

TÜRKEŞ, C., SÖYÜT, H., & BEYDEMİR, Ş., (2015). Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , vol.30, no.4, 622-628.

TÜRKEŞ, CÜNEYT, HAKAN SÖYÜT, And ŞÜKRÜ BEYDEMİR. "Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium," JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , vol.30, no.4, 622-628, 2015

TÜRKEŞ, CÜNEYT Et Al. "Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium." JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , vol.30, no.4, pp.622-628, 2015

TÜRKEŞ, C. SÖYÜT, H. And BEYDEMİR, Ş. (2015) . "Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium." JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY , vol.30, no.4, pp.622-628.

@article{article, author={CÜNEYT TÜRKEŞ Et Al. }, title={Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium}, journal={JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY}, year=2015, pages={622-628} }